M Ishiguro Selected Research

bopindolol

1/2001

Bopindolol: pharmacological basis and clinical implications.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

M Ishiguro Research Topics

Disease

5	Neoplasms (Cancer) 11/2009 - 01/2000
3	Colonic Neoplasms (Colon Cancer) 01/2019 - 09/2014
3	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 09/2012 - 06/2011
2	Brain Ischemia (Cerebral Ischemia) 09/2012 - 06/2011
2	Ischemia 03/2012 - 06/2011
2	Intracranial Vasospasm 01/2008 - 01/2008
2	Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage) 01/2008 - 01/2008
1	Bone Resorption 01/2018
1	Osteoporosis 01/2018
1	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 09/2014
1	Infarction (Infarctions) 09/2012
1	Ischemic Stroke 09/2012
1	Stroke (Strokes) 09/2012
1	Herpes Zoster 03/2012
1	Hypoxia (Hypoxemia) 06/2011
1	Reperfusion Injury 06/2011
1	Colorectal Neoplasms (Colorectal Cancer) 11/2009
1	Neurilemmoma (Schwannoma) 02/2006
1	Neurofibroma 02/2006
1	Neurofibrosarcoma (MPNST) 02/2006
1	Synovial Sarcoma (Synovioma) 08/2001
1	Adamantinoma 08/2001
1	Aneurysm (Aneurysms) 08/2001
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2001
1	Cryptococcosis 12/2000
1	Carcinosarcoma 01/2000

Drug/Important Bio-Agent (IBA)

2	Proteins (Proteins, Gene)FDA Link 06/2011 - 02/2006
1	Zoledronic Acid (Zometa)FDA Link 01/2018
1	Tartrate-Resistant Acid PhosphataseIBA 01/2018
1	Bone Density Conservation AgentsIBA 01/2018
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2015
1	UracilIBA 09/2014
1	Leucovorin (Folinic Acid)FDA Link 09/2014
1	TegafurIBA 09/2014
1	rho-Associated KinasesIBA 09/2012
1	fasudil (AT 877)IBA 09/2012
1	Tissue Plasminogen Activator (Alteplase)FDA Link 09/2012
1	Matrix Metalloproteinase InhibitorsIBA 03/2012
1	Claudin-5IBA 03/2012
1	N- (2(R)- 2- (hydroxamidocarbonylmethyl)- 4- methylpentanoyl)- L- tryptophan methylamideIBA 03/2012
1	OccludinIBA 03/2012
1	Matrix Metalloproteinases (MMPs)IBA 03/2012
1	Tight Junction ProteinsIBA 03/2012
1	Neuroprotective AgentsIBA 06/2011
1	Messenger RNA (mRNA)IBA 06/2011
1	Heparin-binding EGF-like Growth Factor (HB-EGF)IBA 06/2011
1	Epidermal Growth Factor (EGF)IBA 06/2011
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 06/2011
1	Heparin (Liquaemin)FDA LinkGeneric 06/2011
1	Neural Cell Adhesion Molecules (Neural Cell Adhesion Molecule)IBA 11/2009
1	Biological ProductsIBA 11/2009
1	R-Type Calcium Channels (R-Type Calcium Channel)IBA 01/2008
1	Oxyhemoglobins (Oxyhemoglobin)IBA 01/2008
1	Calcium Channels (Calcium Channel)IBA 01/2008
1	Insulin-Like Growth Factor Binding Protein 6IBA 02/2006
1	SurvivinIBA 02/2006
1	Adenosine DeaminaseIBA 02/2006
1	CollagenIBA 02/2006
1	Complementary DNA (cDNA)IBA 02/2006
1	TenascinIBA 02/2006
1	Keratin-18 (Keratin 18)IBA 02/2006
1	Formaldehyde (Formol)FDA Link 08/2001
1	ParaffinIBA 08/2001
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 08/2001
1	SiliconesIBA 08/2001
1	Pharmaceutical PreparationsIBA 04/2001
1	bopindololIBA 01/2001
1	AntigensIBA 12/2000
1	Indicators and Reagents (Reagents)IBA 12/2000
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2000
1	O-(Chloroacetylcarbamoyl)fumagillol (TNP 470)IBA 01/2000
1	Angiogenesis InhibitorsIBA 01/2000
1	fumagillinIBA 01/2000

Therapy/Procedure

1	Lymph Node Excision (Lymph Node Dissection) 01/2019
1	Intravenous Administration 01/2018
1	Adjuvant Chemotherapy 09/2014
1	Combination Drug Therapy (Combination Chemotherapy) 09/2014
1	Therapeutics 09/2012
1	Surgical Instruments (Clip) 08/2001
1	Lasers (Laser) 08/2001
1	Radiotherapy 01/2000